EU: 2nd Covid-19 vaccine expected to be approved in coming hours

Charles Michel
Charles Michel address press conference in Lisbon. (© European Union)

Tista' taqra bil- Malti.

The European Union (EU) is expected to approve the 2nd Covid-19 vaccine in the next hours, according to the President of the European Council (EC) Charles Michel.

This was announced during a press conference marking Portugal taking over the rotating presidency of the EU.

The vaccine, produced by Moderna, has so far been authorised by the US, Canada and Israel. Additional authorisations are currently under review in Singapore, Switzerland and the United Kingdom. The Moderna vaccine has not yet been authorised by the EU, but it is expected that the Committee for Medicinal Products for Human Use human medicines committee are to reconvene on Wednesday.

The EU has only approved one vaccine so far, the BioNTech u Pfizer one, for distribution and use across the EU.

Michel stated that the EU is doing its best to increase distribution of the vaccine, it is still important to acknowledge the independence of the European Agency for Medicines. This is because it serves as a garauntee for the transparency and credibility of the process.

Furthermore, the EU had an important role in the development of these vaccines, particularly by signing contracts for purchase. These contracts were not only signed for vaccines developed by Pfizer/BioNTech, Moderna and Oxford/AstraZeneca, but also for those developed by Sanofi-GSK, CureVac and Janssen.